Oxygen Therapy Management

Initiation and Titration

Start with a prescribed flow rate and titrate oxygen flow to maintain SpO₂ >90% during at least 95% of sleep time, as recommended by the American Thoracic Society 1
Increase oxygen flow by 1 L/min if nocturnal SpO₂ is <90% for more than 5% of the time 1, 2
Initial flow rate for nocturnal supplemental oxygen should be 1-2 L/min via nasal cannula, as suggested by the British Thoracic Society 2
Titrate oxygen flow rates to maintain SpO2 ≥90% during sleep, according to guidelines from the American College of Chest Physicians and the American Thoracic Society 3, 1

In non-hypercapnic patients, consider increasing oxygen flow by 1 L/min during sleep 2
In patients at risk of hypercapnia, monitor arterial blood gases after each flow adjustment and carefully monitor for CO₂ retention 2
Perform arterial blood gas analysis after each flow titration and watch for signs of respiratory acidosis 2
Rule out other causes of nocturnal desaturation, such as obesity hypoventilation syndrome, respiratory muscle weakness, or cardiac disease, as suggested by the British Thoracic Society 2

Nocturnal pulse oximetry is essential to evaluate the need to continue, reduce, or discontinue home oxygen therapy 1
Follow-up should be performed 3 months after initiating or adjusting oxygen therapy, including an evaluation of blood gases and flow to ensure therapy remains necessary and effective 2
Schedule follow-up visits every 6-12 months after the initial 3-month follow-up 2
Long-term monitoring should include follow-up visits at 6-12 months after initial 3-month follow-up to monitor for potential development of hypercapnia, especially in patients with underlying lung disease 2
Supplemental oxygen therapy should be prescribed for patients with moderate nocturnal hypoxia who have a negative OSA diagnosis to maintain oxygen saturation above 90% during sleep, as recommended by the American College of Chest Physicians 3
Nocturnal oxygen therapy should not be given to patients with interstitial lung disease with nocturnal hypoxemia alone who do not fulfill long-term oxygen therapy criteria, according to the British Thoracic Society guidelines 2

The American Thoracic Society guidelines support the use of supplemental oxygen for patients with severe nocturnal hypoxemia who cannot tolerate positive airway pressure therapy or are awaiting surgical treatment of sleep-disordered breathing 1
Inadequate follow-up and failure to regularly assess the continued need and effectiveness of therapy can lead to unnecessary treatment, as warned by the British Thoracic Society 2
Missing alternative diagnoses, such as obesity hypoventilation syndrome or cardiac causes, can result in persistent hypoxemia despite oxygen therapy, as noted by the British Thoracic Society 2
Insufficient titration of oxygen flow rates may result in persistent hypoxemia, as highlighted by the American Thoracic Society 1